Community pharmacies in the UK will receive fairer funding as part of the annual settlement, according to recent announcements. This change aims to address previous funding disparities and provide more equitable support for community pharmacies.
Migraine and acne have been added to new prescribing pathways under the Pharmacy First program, allowing pharmacists to play a greater role in treating these conditions. The expansion of services is expected to improve patient access to care and reduce the burden on other healthcare providers.
They will help ensure that patients receive safe and effective treatment for their conditions.
A GP practice has introduced a new medicines management policy for high-risk drugs following the death of a patient. It aims to improve the safe use of high-risk medications and prevent similar incidents in the future.
Read Also: NHS to offer Enhertu to breast cancer patients
There has been a sharp increase in AI-generated complaints, with fitness to practise concerns rising by a third. This trend highlights the need for healthcare professionals to be aware of the potential risks and benefits associated with AI-generated complaints.
NICE made this decision due to concerns about the treatment’s cost-effectiveness and the availability of alternative options.
A community pharmacist prescribing service is planned to start in October 2026, which will allow pharmacists to prescribe medications for certain conditions.